Caricamento...
An IgG1 version of the Anti-Transferrin Receptor 1 Antibody ch128.1 Shows Significant Anti-tumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication
The transferrin receptor 1 (TfR1) is a meaningful target for antibody-based cancer therapy given its overexpression on malignant cells and its central role in cancer pathology. We previously developed a mouse/human chimeric IgG3 targeting human TfR1 (ch128.1), which exhibits significant anti-tumor a...
Salvato in:
| Pubblicato in: | J Immunother |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7002290/ https://ncbi.nlm.nih.gov/pubmed/31693515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000304 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|